Search Results - "Oliveira, Monica Cristina"
-
1
Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model
Published in Biomedicine & pharmacotherapy (01-10-2019)“…Long circulating pH-sensitive liposomes have been shown to effectively deliver doxorubicin (DOX) to tumors and reduce its toxic effects. Folic acid receptors…”
Get full text
Journal Article -
2
pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment
Published in Biomedicine & pharmacotherapy (01-12-2021)“…Irinotecan (IRN) is a semisynthetic derivative of camptothecin that acts as a topoisomerase I inhibitor. IRN is used worldwide for the treatment of several…”
Get full text
Journal Article -
3
Combination of the Topical Photodynamic Therapy of Chloroaluminum Phthalocyanine Liposomes with Fexinidazole Oral Self-Emulsifying System as a New Strategy for Cutaneous Leishmaniasis Treatment
Published in Pharmaceutics (01-04-2024)“…Cutaneous leishmaniasis (CL) is a neglected tropical disease. The treatment is restricted to drugs, such as meglumine antimoniate and amphotericin B, that…”
Get full text
Journal Article -
4
PEGylated versus Non-PEGylated pH-Sensitive Liposomes: New Insights from a Comparative Antitumor Activity Study
Published in Pharmaceutics (24-01-2022)“…PEGylated liposomes are largely studied as long-circulating drug delivery systems. Nevertheless, the addition of PEG can result in reduced interactions between…”
Get full text
Journal Article -
5
Physicochemical Characterization and Skin Permeation of Cationic Transfersomes Containing the Synthetic Peptide PnPP-19
Published in Current drug delivery (01-01-2018)“…PnPP-19 is a 19-amino-acid synthetic peptide previously described as a novel drug for the treatment of erectile dysfunction. The aim of this work was to…”
Get more information
Journal Article -
6
Triggered Drug Release From Liposomes: Exploiting the Outer and Inner Tumor Environment
Published in Frontiers in oncology (16-03-2021)“…Since more than 40 years liposomes have being extensively studied for their potential as carriers of anticancer drugs. The basic principle behind their use for…”
Get full text
Journal Article -
7
Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal model
Published in Biomedicine & pharmacotherapy (01-01-2019)“…[Display omitted] •Treatment of murine breast cancer with LCFL-PTX/DXR is superior to treatments with free PTX or free DXR.•No heart damage is observed when…”
Get full text
Journal Article -
8
The effect of free and encapsulated cisplatin into long-circulating and pH-sensitive liposomes on IEC-6 cells during wound healing in the presence of host–microbiota
Published in Journal of pharmacy and pharmacology (20-05-2022)“…Abstract Objectives To circumvent cisplatin (CDDP) toxic effects and improve the antitumoural effect, our research group developed long-circulating and…”
Get full text
Journal Article -
9
Physical and biological effects of paclitaxel encapsulation on disteraroylphosphatidylethanolamine-polyethyleneglycol polymeric micelles
Published in Colloids and surfaces, B, Biointerfaces (01-04-2020)“…[Display omitted] •SAXS analysis showed that encapsulation of paclitaxel affected the micelle packing.•Core radius increased while shell radius shrank, without…”
Get full text
Journal Article -
10
Evaluation of acute toxicity and in vitro antitumor activity of a novel doxorubicin-loaded folate-coated pH-sensitive liposome
Published in Biomedicine & pharmacotherapy (01-09-2023)“…Doxorubicin (DOX) loaded liposomes have been used and studied in the last decades due to the significant decrease in DOX induced cardiac and systemic toxicity…”
Get full text
Journal Article -
11
Paclitaxel-Loaded Folate-Coated pH-Sensitive Liposomes Enhance Cellular Uptake and Antitumor Activity
Published in Molecular pharmaceutics (05-08-2019)“…Paclitaxel (PTX) is a microtubule-stabilizing agent widely used to treat breast cancer. Nevertheless, the low solubility of the drug and the side effects of…”
Get full text
Journal Article -
12
Preclinical toxicological study of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in synergic ratio
Published in Biomedicine & pharmacotherapy (01-12-2021)“…Combination therapy between paclitaxel (PTX) and doxorubicin (DXR) is applied as the first-line treatment of breast cancer. Co-administration of drugs at…”
Get full text
Journal Article -
13
Mechanistic insights into the intracellular release of doxorubicin from pH-sensitive liposomes
Published in Biomedicine & pharmacotherapy (01-02-2021)“…[Display omitted] •The release from pH-sensitive liposomes is more complex than only intraluminal pH decreases.•pH-sensitive liposomes released doxorubicin…”
Get full text
Journal Article -
14
Short and Long-Term Effects of the Exposure of Breast Cancer Cell Lines to Different Ratios of Free or Co-Encapsulated Liposomal Paclitaxel and Doxorubicin
Published in Pharmaceutics (11-04-2019)“…Associating paclitaxel (PTX) to doxorubicin (DXR) is one of the main chemotherapy strategies for breast cancer (BC) management. Protocols currently available…”
Get full text
Journal Article -
15
Technetium-99m-labeled stealth pH-sensitive liposomes: a new strategy to identify infection in experimental model
Published in Brazilian archives of biology and technology (01-09-2007)“…The diagnosis of inflammatory and infectious processes is an important goal in medicine. The use of radiopharmaceuticals for identification of inflammation and…”
Get full text
Journal Article -
16
Investigation of the Antitumor Activity and Toxicity of Tumor-Derived Exosomes Fused with Long-Circulating and pH-Sensitive Liposomes Containing Doxorubicin
Published in Pharmaceutics (22-10-2022)“…Exosome–liposome hybrid nanocarriers containing chemotherapeutic agents have been developed to enhance drug delivery, improve the efficacy of the treatment of…”
Get full text
Journal Article -
17
Intestinal toxicity evaluation of long-circulating and pH-sensitive liposomes loaded with cisplatin
Published in European journal of pharmaceutical sciences (30-08-2017)“…Cisplatin (CDDP) is a chemotherapeutic agent widely used in several anticancer protocols for instance head and neck, testicle, ovarian, lung and peritoneal…”
Get full text
Journal Article -
18
Liposomal paclitaxel induces apoptosis, cell death, inhibition of migration capacity and antitumoral activity in ovarian cancer
Published in Biomedicine & pharmacotherapy (01-10-2021)“…The main goal of this study is to evaluate the efficacy of the paclitaxel (PTX) drug formulated with a liposomal nanosystem (L-PTX) in a peritoneal…”
Get full text
Journal Article -
19
Development of a bone-targeted pH-sensitive liposomal formulation containing doxorubicin: physicochemical characterization, cytotoxicity, and biodistribution evaluation in a mouse model of bone metastasis
Published in International journal of nanomedicine (2016)“…Despite recent advances in cancer therapy, the treatment of bone tumors remains a major challenge. A possible underlying hypothesis, limitation, and unmet need…”
Get full text
Journal Article -
20
Hybrid Nanosystem Formed by DOX-Loaded Liposomes and Extracellular Vesicles from MDA-MB-231 Is Effective against Breast Cancer Cells with Different Molecular Profiles
Published in Pharmaceutics (01-06-2024)“…Drug delivery selectivity is a challenge for cancer treatment. A hybrid pegylated pH-sensitive liposome-extracellular vesicle isolated from human breast cancer…”
Get full text
Journal Article